Insiders Lyra Therapeutics, Inc.

Equities

LYRA

US55234L1052

Real-time Estimate Cboe BZX Other stock markets 18:18:56 14/05/2024 BST			5-day change	1st Jan Change
0.364 ^USD	+0.39%		-12.81%	-93.01%

05-07	Jefferies Downgrades Lyra Therapeutics to Hold, Price Target at $0.50	MT
05-07	HC Wainwright Downgrades Lyra Therapeutics to Neutral From Buy	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lyra Therapeutics, Inc. Announces Board Changes	04-19	CI
Lyra Therapeutics, Inc Announces Appointment of Ronan O?Brien as Chief Legal Officer	16/10/23	CI
Insider Buy: Lyra Therapeutics	02/06/23	MT
Insider Buy: Lyra Therapeutics	02/06/23	MT
Lyra Therapeutics Names John Bishop CTO	27/02/23	MT
Lyra Therapeutics, Inc. Announces Appointment of John Bishop as Chief Technology Officer	27/02/23	CI
Lyra Therapeutics Announces Appointment of Richard Nieman, Md, as Chief Medical Officer, Effective July 11, 2022	05/07/22	CI
Insider Buy: Lyra Therapeutics	14/04/22	MT
Lyra Therapeutics, Inc. Appoints Jim Tobin to Board of Directors	07/03/22	CI
Lyra Therapeutics Appoints Harlan W. Waksal as Executive Chairman	17/02/22	CI
Lyra Therapeutics : Names Jason Cavalier Finance Chief	13/09/21	MT
Lyra Therapeutics Announces Appointment of Robert Kern as Chief Medical Officer	17/02/21	CI
Lyra Therapeutics, Inc. Appoints Nancy Snyderman, to the Compensation Committee of the Board	10/12/20	CI
Lyra Therapeutics, Inc. Announces Board Changes	28/10/20	CI
Lyra Therapeutics Announces Pamela Nelson as Senior Vice President of Regulatory Affairs	04/08/20	CI
Laura Edgerly-Pflug Ceases to Be Senior Vice President of Technical Operations of Lyra Therapeutics, Inc	24/07/20	CI
Lyra Therapeutics Announces Robert Richard as Senior Vice President of Research and Development	07/07/20	CI
Lyra Therapeutics Appoints Bradford Smith to its Board of Directors	19/11/19	CI
Lyra Therapeutics, Inc. Announces Dana Washburn as Chief Medical Officer	10/10/19	CI
Lyra Therapeutics, Inc. Appoints Ann Merrifield to its Board of Directors	04/09/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Lyra Therapeutics, Inc.

Equities

LYRA

US55234L1052

Insiders

Filters